Healthcare systems are not built to translate today’s micro-level diagnostics into safe, consistent patient care.

• Primary care providers and networks cannot manage the volume and complexity of requirements needed for care based on molecular diagnostics
• Independent laboratories lack the context to know which molecular tests to validate, or how to ensure those tests are clinically applied with accuracy and consistency.
• Research institutions excel at discovery but are not structured to operationalize results into everyday clinical practice.
• Specialist scientists – pathologists, microbiologists, molecular experts – cannot simultaneously conduct research, run independent practices, provide patient care, and operate advanced laboratories.

The BioConnetiX Advantage

BioConnetiX gives payors a proven method to control utilization, reduce redundancy, and manage costly disease processes system-wide. We work directly with insurance networks to design programs that deliver:

• Immediate utilization controls and cost containment
• Measured, staged implementation of evidence-based workflows
• Ongoing pathway management with full financial risk assumed by BioConnetiX

Once your plan is approved, we manage the rest.

BioConnetiX develops customized programs that:

• Control utilization and pricing of advanced laboratory diagnostics
• Manage costly and complex disease processes
• Eliminate redundancy and financial risk through structured pathways
• Provide transparent reporting at every stage of integration

As systems advance, BioConnetiX delivers deeper insights and additional metrics – empowering insurers with the data needed to make smarter coverage and policy decisions. Over time, larger datasets enable earlier identification of patient risks at a fraction of current costs.

Insurance companies piloting BioConnetiX frameworks for specific clinical pathways see near-term cost savings and deep impact. Our targeted programs can address high-cost injuries and disease processes without the delays of legacy infrastructure – delivering early wins while building scalable models. Results data from these programs refine Early Warning Score (EWS) indicators, drug-dose guidance, and other clinical protocols across the network, continuously reducing risk and cost.

BioConnetiX connects the complex ecosystem of care providers required to transform fragmented, costly micro-diagnostics into evidence-based, personalized care from a foundation in molecular science. It is the first healthcare platform of its kind to harness physician, scientist and operator specialization to comprehensively manage the entire continuum of care. Extensive partner collaboration with payors, healthcare networks, research institutions, molecular pathologists & microbiologists, and laboratory operators is paramount in our ability to capture the full value of analytic medicine.

Clinical standards and value are addressed by integrating foundations from medical practice into advanced diagostics and personalized medicine through regimented operational deployment. Pricing risk is offloaded from payers by BioConnetiX. Utilization outlier detection, telehealth-driven workup and care plan management occur upon deployment and progress through a series of increasingly ambitious operational, clinical and financial thresholds. Clinical pathways are supported with sophisticated decision-support technology. Specialization, standardization, centralization, and alignment with credentialed laboratories allow for dramatically reduced costs and timely, consistent performance. Analytics measures report user adherence to protocols, clinical and financial outcomes, benchmark performance data, and a growing set of other measures.